Raija Silvennoinen
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients (NCT03376672) | Raija Silvennoinen | 2018-05-31 |
Track Raija Silvennoinen automatically
Every clearance here is in the API, with alerts when new ones post.